[1] [1] I. Erol, F. Alehan, F. Ozcay, O. Canan, M. Haberal, "Neurological complications of liver transplantation in pediatric patients: A single center experience," Pediatr. Transplant. 11(2), 152–159 (2007).

[2] [2] B. Ostadal, "The past, the present and the future of experimental research on myocardial ischemia and protection," Pharmacol. Rep. 61(1), 3–12 (2009).

[3] [3] C. M. Cheung, A. Ponnusamy, J. G. Anderton, "Management of acute renal failure in the elderly patient," Drug. Aging 25(6), 455–476 (2008).

[4] [4] P. Renner, K. Kienle, M. H. Dahlke, P. Heiss, K. Pfister, C. Stroszczynski, P. Piso, H. J. Schlitt, "Intestinal ischemia: Current treatment concepts," Langenbeck. Arch. Surg. 396(1), 3–11 (2011).

[5] [5] G. L. Semenza, "Oxygen-regulated transcription factors and their role in pulmonary disease," Resp. Res. 1(3), 159 (2000).

[6] [6] G. Oliu, S. Nogue, O. Miro, "Carbon monoxide poisoning: Pathophysiologic principles underlying good treatment," Emergencias 22(6), 451–459 (2010).

[7] [7] I. Timofeev, M. Czosnyka, K. L. Carpenter, J. Nortje, P. J. Kirkpatrick, P. G. Al-Rawi, D. K. Menon, J. D. Pickard, A. K. Gupta, P. J. Hutchinson, "Interaction between brain chemistry and physiology after traumatic brain injury: Impact of autoregulation and microdialysis catheter location," J. Neurotrauma. 28(6), 849–860 (2011).

[8] [8] E. Borg, "Perinatal asphyxia, hypoxia, ischemia and hearing loss: An overview," Scand. Audiol. 26(2), 77–91 (1997).

[9] [9] R. J. Sung, M. R. Lauer, "Sudden cardiac death syndrome: Diagnosis and management," J. Formos. Med. Assoc. 99(11), 809–822 (2000).

[10] [10] T. O'connor, G. Dubowitz, P. E. Bickler, "Pulse oximetry in the diagnosis of acute mountain sickness," High Alt. Med. Biol. 5(3), 341–348 (2004).

[11] [11] M. S. Koehle, J. A. Guenette, D. E. Warburton, "Oximetry, heart rate variability, and the diagnosis of mild-to-moderate acute mountain sickness," Eur. J. Emerg. Med. 17(2), 119–122 (2010).

[12] [12] A. B. Valadka, J. C. Goodman, S. P. Gopinath, M. Uzura, C. S. Robertson, "Comparison of brain tissue oxygen tension to microdialysis-based measures of cerebral ischemia in fatally head-injured humans," J. Neurotrauma. 15(7), 509–519 (1998).

[13] [13] M. F. Stiefel, A. Spiotta, V. H. Gracias, A. M. Garuffe, O. Guillamondegui, E. Maloney-Wilensky, S. Bloom, M. S. Grady, P. D. Leroux, "Reduced mortality rate in patients with severe traumatic brain injury treated with brain tissue oxygen monitoring," J. Neurosurg. 103(5), 805–811 (2005).

[14] [14] J. Nunn, "Cerebral oxygen transport consumption and metabolism: Transport of oxygen to the brain: Respiratory, circulatory and biochemical factors," Acta Anaesth. Scand. 15(s45), 69–77 (1971), "Transport of oxygen and carbon dioxide in blood and tissue fluids", Chap. 40, Textbook of Medical Physiology, A. C. Guyton, J. E. Hall, Eds., pp. 502– 513, Elsevier Health Sciences, Philadelphia (2006).

[15] [15] B. Chance, N. Oshino, T. Sugano, A. Mayevsky, "Basic principles of tissue oxygen determination from mitochondrial signals," Adv. Exp. Med. Biol. 37, 277–292 (1973).

[16] [16] H. Shi, N. Sun, A. Mayevsky, Z. Zhang, Q. Luo, "Preclinical evidence of mitochondrial nicotinamide adenine dinucleotide as an effective alarm parameter under hypoxia," J. Biomed. Opt. 19(1), 017005 (2014).

[17] [17] G. J. Tortora, B. H. Derrickson, Principles of Anatomy and Physiology, John Wiley & Sons (2008).

[18] [18] A. Mayevsky, B. Chance, "Intracellular oxidationreduction state measured in situ by a multichannel fiber-optic surface fluorometer," Science 217(4559), 537 (1982).

[19] [19] A. Mayevsky, G. G. Rogatsky, "Mitochondrial function in vivo evaluated by NADH fluorescence: From animal models to human studies," Am. J. Physiol. Cell Physiol. 292(2), C615–C640 (2007).

[20] [20] A. Mayevsky, "Mitochondrial function and energy metabolism in cancer cells: Past overview and future perspectives," Mitochondrion 9(3), 165–179 (2009).

[21] [21] B. Chance, P. Cohen, F. Jobsis, B. Schoener, "Intracellular oxidation-reduction states in vivo," Science 137(3529), 499–508 (1962).

[22] [22] A. Mayevsky, E. Barbiro-Michaely, "Shedding light on mitochondrial function by real time monitoring of NADH fluorescence: I. Basic methodology and animal studies," J. Clin. Monit. Comput. 27(1), 1–34 (2013).

[23] [23] E. M. Scott, I. W. Duncan, V. Ekstrand, "The reduced pyridine nucleotide dehydrogenases of human erythrocytes," J. Biol. Chem. 240(1), 481– 485 (1965).

[24] [24] M. F. Perutz, E. J. Heidner, J. E. Ladner, J. G. Beetlestone, C. Ho, E. F. Slade, "Influence of globin structure on the state of the heme. III. Changes in heme spectra accompanying allosteric transitions in methemoglobin and their implications for hemeheme interaction," Biochemistry 13(10), 2187–2200 (1974).

[25] [25] G. T. Trevisani, S. R. Shackford, J. Zhuang, J. D. Schmoker, "Brain edema formation after brain injury, shock, and resuscitation: Effects of venous and arterial pressure," J. Trauma Inj. Infect. Crit. Care 37(3), 452–458 (1994).

[26] [26] M. Dawkins, J. Judah, K. Rees, "The effect of chlorpromazine on the respiratory chain. Cytochrome oxidase," Biochem. J. 72(2), 204 (1959).

[27] [27] P. H. Bulle, "Effects of reserpine and chlorpromazine in prevention of cerebral edema and reversible cell damage," Exp. Biol. Medi. 94(3), 553–556 (1957).

[28] [28] A. Mayevsky, E. Barbiro-Michaely, "Shedding light on mitochondrial function by real time monitoring of NADH fluorescence: II: Human studies," J. Clin. Monit. Comput. 27(2), 125–145 (2013).